�鶹��ý

Skip to main content

Search

English

Servicemenu

News
Events
- Previous Events
Contact

Hovedmenu

Business activities
Grants & Prizes
- Press and logo
About us
Exchange offer

Hovedmenu - mobil

Business activities
Grants & Prizes
- Press and logo
About us
Exchange offer

Servicemenu - mobil

News
Events
- Previous Events
Contact

English

Breadcrumb

Home
Business activities
�鶹��ý BioCapital
�鶹��ý BioCapital News

�鶹��ý BioCapital News

Latest news about �鶹��ý BioCapital and their investments.

Closing the innovation gap

18 December 2025

Turning academic discoveries into future medicines
�鶹��ý BioCapital

13 May 2025

What makes a great life science venture capital fund?
�鶹��ý BioCapital

19 February 2025

Turning sustainability into tangible business benefits
�鶹��ý BioCapital

9 December 2024

SNIPR Biome receives up to EUR 20 mill. European backing
�鶹��ý BioCapital

3 July 2024

�鶹��ý BioCapital invests in Danish quantum start-up Kvantify
Vesper Bio

7 December 2023

Vesper Bio doses first volunteer in Phase I study of first-in-class oral treatment for Frontotemporal Dementia (FTD)
Press Release

18 October 2023

Venture forces invest millions in new type of treatment for particularly aggressive form of cancer
Press Release

25 September 2023

�鶹��ý BioCapital and +ND Capital join forces: New investment in novel hormone-free fertility treatment for women
The team expands

30 August 2023

Jan-Erik Messling is a new young talent at �鶹��ý BioCapital
�鶹��ý BioCapital

19 December 2022

2022: We reflect on the eventful year in our portfolio.

Pagination

Current page 1
Page 2
Page 3
Next page
Last page

Business activities

�鶹��ý BioCapital Strategic ownerships Invest

Grants and prizes

For applicants For grant recipients Fundings Research stories

International activities

The Brain Prize

About us

The organisation All of us Statutes and history Strategy and purpose Social responsibility and transparency Publications Events Job opportunities

The Lundbeck Foundation annually distributes more than DKK 500 mio. to Danish-based healthcare science research, primarily with a focus on the brain.

�鶹��ý
Scherfigsvej 7
DK-2100 Copenhagen Ø
Denmark

CVR

11814913

Follow us

Contact
Whistleblower
Cookie-Policy
Disclaimer & Privacy